Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Syros Pharmaceuticals
(NQ:
SYRS
)
2.530
+0.100 (+4.12%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
132,998
Open
2.420
Bid (Size)
2.510 (1)
Ask (Size)
2.590 (2)
Prev. Close
2.430
Today's Range
2.420 - 2.590
52wk Range
1.430 - 8.170
Shares Outstanding
20,595,503
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update
October 31, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
October 24, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Performance
YTD
-67.73%
-67.73%
1 Month
+30.41%
+30.41%
3 Month
-51.35%
-51.35%
6 Month
-50.20%
-50.20%
1 Year
-9.64%
-9.64%
More News
Read More
Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
September 04, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
August 27, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Syros Pharmaceuticals to Present at Upcoming Medical and Investor Conferences
August 27, 2024
From
Syros Pharmaceuticals
Via
Business Wire
SYRS Investors Have Opportunity to Join Syros Pharmaceuticals, Inc. Securities Fraud Investigation with the Schall Law Firm
August 20, 2024
From
The Schall Law Firm
Via
Business Wire
Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
August 13, 2024
Via
Benzinga
Exposures
Fossil Fuels
S&P 500 Gains 1%; Home Depot Earnings Top Views
August 13, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
August 13, 2024
Via
Benzinga
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
Via
Benzinga
Why Is Syros Pharmaceuticals (SYRS) Stock Down 62% Today?
August 13, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 13, 2024
Via
InvestorPlace
Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
August 13, 2024
Via
Benzinga
Syros Provides Update on SELECT-AML-1 Phase 2 Clinical Trial
August 12, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Syros Reports Second Quarter 2024 Financial Results and Provides a Business Update
July 31, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Syros to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024
July 24, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene Overexpression
June 13, 2024
From
Syros Pharmaceuticals
Via
Business Wire
SYRS Stock Earnings: Syros Pharmaceuticals Beats EPS for Q1 2024
May 14, 2024
Via
InvestorPlace
Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 14, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Syros to Participate in Upcoming Investor Conferences
May 07, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
May 07, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Crude Oil Down Over 1%; Cognyte Software Shares Plummet
April 09, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 09, 2024
Via
Benzinga
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
April 09, 2024
From
Syros Pharmaceuticals
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
